ArticleScientific reports2026
Clinico-pathologic characteristics of sub-epithelial tumor (SET) like gastric cancers.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It has been known that sub-epithelial tumor (SET)-like gastric cancer (GC) is a special type of gastric cancer with a relatively low prevalence of approximately 1%. Most of the studies are old and would be underestimated. Recently, the application of endoscopic ultrasound has increased, so its frequency is expected to increase. A consecutive study was undertaken from March 2020 to March 2024, and we analyzed 380 GC tissues (194 early GCs; 186 advanced GCs) from the patients who had received gastrectomy or endoscopic submucosal dissection. Through picture archiving and communication system, the endoscopic findings at the time of diagnosis were analyzed. After removal, molecular biological characteristics were examined. The prevalence of SET like GC was 5.8% (22/ 380) endoscopically. There were no differences between the SET like GC and the other group with respect to gender, smoking, drinking history, and Helicobacter pylori infection. SET like GC patients were statistically older (P = 0.04). The frequency of advanced GC (P = 0.03) and the frequency of microsatellite instability (MSI) (P < 0.01) were statistically higher in SET like GC. Exceptional cases included Epstein-Barr virus-associated lymphoepithelioma-like carcinoma, undifferentiated carcinoma with rhabdoid features, mixed neuroendocrine tumor, case with gastritis cystica profunda, and cases that used anti-ulcer drugs or responded to chemotherapy. It also appeared in gastric cancer with confirmed genetic predisposition. SET like GC had many advanced cases and MSI-positive GCs. If we investigate various exceptional cases, it is likely that their frequency will continue to increase. We urgently need measures to address this.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.